
  
    
      
        Introduction_NNP
        Conventional_JJ cancer_NN incidence_NN rates_NNS contain_VBP new_JJ cases_NNS of_IN
        the_DT disease_NN for_IN a_DT given_VBN year_NN in_IN the_DT numerator_NN and_CC the_DT
        mid-year_JJ population_NN in_IN the_DT denominator_NN [_NN 1_CD ]_NN ._. However_RB ,_,
        this_DT rate_NN is_VBZ potentially_RB problematic_JJ for_IN those_DT cancers_NNS in_IN
        which_WDT the_DT denominator_NN includes_VBZ cases_NNS not_RB at-risk_JJ of_IN
        developing_VBG the_DT disease_NN [_NN 2_CD ]_NN ._. For_IN example_NN ,_, a_DT large_JJ portion_NN
        of_IN the_DT female_JJ population_NN will_MD undergo_VB a_DT hysterectomy_NN in_IN
        their_PRP$ lifetime_NN [_NN 2_CD 3_CD 4_CD ]_NN ,_, removing_VBG them_PRP from_IN being_VBG at_IN risk_NN
        of_IN developing_VBG corpus_NN uterine_NN cancer_NN ._. In_IN addition_NN ,_, a_DT woman_NN
        with_IN cancer_NN of_IN the_DT corpus_NN uterine_NN is_VBZ very_RB unlikely_JJ to_TO be_VB
        diagnosed_VBN with_IN the_DT disease_NN a_DT second_JJ time_NN [_NN 2_CD ]_NN ._. Hence_RB ,_,
        these_DT women_NNS should_MD be_VB removed_VBN from_IN the_DT at-risk_JJ population_NN
        in_IN the_DT rate_NN calculation_NN ._.
        In_IN the_DT mid_JJ 1970_CD s_VBZ ,_, Lyon_NNP and_CC Gardner_NNP presented_VBD a_DT method_NN
        for_IN obtaining_VBG hysterectomy_NN prevalence_NN and_CC applied_VBD it_PRP to_TO
        uterine_NN cancers_NNS in_IN order_NN to_TO produce_VB corrected_VBN incidence_NN and_CC
        mortality_NN rates_NNS [_NN 5_CD ]_NN ._. The_DT approach_NN used_VBD the_DT prevalence_NN of_IN
        hysterectomy_NN ,_, as_IN determined_VBN by_IN the_DT United_NNP States_NNPS Health_NNP
        Examination_NNP Survey_NN of_IN 1960_CD -_: 1962_CD [_NN 6_CD ]_NN ,_, and_CC a_DT cohort_NN model_NN
        population_NN applied_VBN to_TO the_DT 1960_CD United_NNP States_NNPS female_JJ
        population_NN ._. This_DT population_NN was_VBD corrected_VBN over_IN time_NN by_IN
        hysterectomy_NN rates_NNS obtained_VBN from_IN the_DT National_NNP Hospital_NNP
        Discharge_NNP Survey_NNP ,_, a_DT survey_NN providing_VBG annual_JJ probability_NN
        samples_NNS of_IN hospital_NN discharges_NNS from_IN nonfederal_NN ,_, short-stay_JJ
        hospitals_NNS [_NN 7_CD ]_NN ._. A_DT more_RBR recent_JJ study_NN provided_VBN corrected_VBN
        uterine_NN cancer_NN rates_NNS for_IN the_DT United_NNP States_NNPS by_IN applying_VBG the_DT
        method_NN proposed_VBN by_IN Lyon_NNP and_CC Gardner_NNP and_CC using_VBG hysterectomy_NN
        rates_NNS from_IN the_DT National_NNP Hospital_NNP Discharge_NNP Survey_NNP through_IN
        1992_CD [_NN 2_CD ]_NN ._.
        Two_CD other_JJ methods_NNS may_MD be_VB used_VBN to_TO obtain_VB hysterectomy_NN
        prevalence_NN estimates_VBZ that_WDT have_VBP an_DT advantage_NN in_IN that_IN they_PRP do_VBP
        not_RB require_VB several_JJ years_NNS of_IN follow-up_JJ data_NNS to_TO obtain_VB
        hysterectomy_NN prevalence_NN estimates_NNS ._. The_DT first_JJ involves_VBZ
        calculating_VBG hysterectomy_NN prevalence_NN estimates_NNS by_IN applying_VBG
        cross-sectional_JJ hysterectomy_NN incidence_NN and_CC all-cause_JJ
        mortality_NN data_NNS to_TO single-_NN and_CC double-decrement_JJ life_NN tables_NNS
        [_NN 8_CD ]_NN ._. However_RB ,_, this_DT approach_NN may_MD be_VB limited_VBN by_IN trends_NNS in_IN
        the_DT data_NNS ._. A_DT second_JJ approach_NN obtains_NNS prevalence_NN estimates_NNS
        directly_RB from_IN responses_NNS to_TO cross-sectional_JJ survey_NN data_NNS ._. An_DT
        advantage_NN of_IN this_DT method_NN is_VBZ that_IN it_PRP does_VBZ not_RB require_VB
        complicated_VBN modeling_NN ,_, but_CC it_PRP may_MD be_VB limited_VBN by_IN potential_JJ
        biases_NNS that_WDT affect_VBP self-reported_JJ survey_NN data_NNS ._.
        The_DT purpose_NN of_IN this_DT paper_NN is_VBZ to_TO describe_VB these_DT two_CD
        methods_NNS for_IN correcting_VBG corpus_NN uterine_NN cancer_NN incidence_NN
        rates_NNS and_CC probabilities_NNS ._. The_DT methods_NNS yield_VBP estimates_NNS of_IN the_DT
        proportion_NN of_IN the_DT population_NN at_IN risk_NN for_IN developing_VBG the_DT
        disease_NN and_CC correct_VB the_DT incidence_NN rates_NNS and_CC probabilities_NNS
        accordingly_RB ._. Although_IN the_DT focus_NN is_VBZ on_IN corpus_NN uterine_NN
        cancer_NN ,_, the_DT same_JJ methods_NNS may_MD be_VB applied_VBN to_TO other_JJ cancers_NNS of_IN
        the_DT female_JJ genital_JJ system_NN ,_, such_JJ as_IN of_IN the_DT cervix_NN uteri_NN or_CC
        ovaries_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Method_NNP 1_CD ._. Life-table_NNP method_NN of_IN estimating_VBG
          hysterectomy_NN prevalence_NN
          A_DT single-decrement_JJ life_NN table_NN was_VBD used_VBN to_TO calculate_VB
          the_DT proportion_NN (_( 
          p_NN 1_CD 
          
            x_SYM 
           )_) of_IN a_DT hypothetical_JJ cohort_NN of_IN 10_CD million_CD newborns_NNS
          alive_JJ at_IN the_DT beginning_NN of_IN age_NN interval_NN 
          x_SYM when_WRB exposed_VBN to_TO the_DT
          cross-sectional_JJ hazard_NN of_IN death_NN from_IN all_DT causes_NNS ._. From_IN a_DT
          multiple-decrement_JJ life_NN table_NN ,_, the_DT proportion_NN (_( 
          p_NN 2_CD 
          
            x_SYM 
           )_) of_IN a_DT hypothetical_JJ cohort_NN of_IN newborns_NNS alive_JJ and_CC at_IN
          risk_NN of_IN the_DT disease_NN at_IN the_DT beginning_NN of_IN age_NN interval_NN 
          x_SYM is_VBZ calculated_VBN based_VBN on_IN their_PRP$
          chance_NN of_IN having_VBG undergone_VBN a_DT hysterectomy_NN ,_, having_VBG been_VBN
          diagnosed_VBN with_IN the_DT disease_NN ,_, or_CC dying_VBG of_IN any_DT cause_NN ._. Women_NNP
          having_VBG undergone_VBN a_DT hysterectomy_NN or_CC previously_RB diagnosed_VBN
          with_IN corpus_NN cancer_NN without_IN having_VBG had_VBD a_DT hysterectomy_NN are_NN
          assumed_VBN to_TO reflect_VB those_DT not_RB at_IN risk_NN of_IN developing_VBG the_DT
          disease_NN ._. The_DT prevalence_NN of_IN having_VBG undergone_VBN a_DT
          hysterectomy_NN or_CC having_VBG been_VBN previously_RB diagnosed_VBN with_IN
          corpus_NN uterine_NN cancer_NN (_( minus_CC those_DT having_VBG had_VBD a_DT
          hysterectomy_NN is_VBZ calculated_VBN as_IN 
          P_NN 
          
            x_SYM 
           =_SYM 1_CD -_: (_( 
          p_NN 2_CD 
          
            x_SYM 
           /_NN 
          p_NN 1_CD 
          
            x_SYM 
           )_) ._.
          Estimates_NNS derived_VBN from_IN the_DT life_NN tables_NNS represent_VBP the_DT
          prevalence_NN that_WDT would_MD be_VB observed_VBN if_IN a_DT cohort_NN of_IN
          individuals_NNS were_VBD exposed_VBN to_TO the_DT current_JJ hysterectomy_NN ,_,
          corpus_NN uterine_NN (_( minus_CC those_DT having_VBG had_VBD a_DT hysterectomy_NN )_) ,_,
          and_CC all-cause_JJ mortality_NN rates_NNS over_IN their_PRP$ entire_JJ
          lifetime_NN ._.
        
        
          Method_NNP 2_CD ._. Cross-sectional_NNP survey_NN method_NN for_IN
          estimating_VBG hysterectomy_NN prevalence_NN
          The_DT status_NN of_IN an_DT individual_NN with_IN respect_NN to_TO the_DT
          presence_NN or_CC absence_NN of_IN a_DT disease_NN or_CC health-related_JJ event_NN
          may_MD be_VB obtained_VBN through_IN assessment_NN at_IN a_DT given_VBN point_NN in_IN
          time_NN ._. There_EX are_VBP national_JJ and_CC international_JJ surveys_NNS that_WDT
          track_NN the_DT disease_NN and_CC health_NN status_NN of_IN people_NNS in_IN the_DT
          population_NN ._. For_IN example_NN ,_, the_DT Behavior_NNP Risk_NNP Factor_NN
          Surveillance_NNP System_NNP (_( BRFSS_NNP )_) collects_VBZ information_NN about_IN
          women_NNS 's_POS health_NN issues_NNS ,_, such_JJ as_IN pregnancy_NN and_CC
          hysterectomy_NN ._. A_DT question_NN that_WDT asks_VBZ whether_IN a_DT woman_NN has_VBZ
          ever_RB had_VBD a_DT hysterectomy_NN ,_, along_IN with_IN solicitation_NN of_IN the_DT
          woman_NN 's_POS current_JJ age_NN ,_, indicates_VBZ the_DT prevalent_JJ proportion_NN
          of_IN women_NNS who_WP have_VBP had_VBD a_DT hysterectomy_NN by_IN a_DT certain_JJ
          age_NN ._.
        
        
          Corrected_NNP denominators_NNS in_IN the_DT cancer_NN rate_NN
          calculation_NN
          In_IN order_NN to_TO correct_VB the_DT denominator_NN in_IN the_DT rate_NN
          calculation_NN of_IN corpus_NN uterine_NN cancer_NN ,_, we_PRP need_VBP to_TO alter_VB
          the_DT population_NN so_IN that_IN it_PRP reflects_VBZ women_NNS at_IN risk_NN of_IN
          developing_VBG the_DT disease_NN ._. We_PRP assume_VBP that_IN a_DT woman_NN is_VBZ at_IN risk_NN
          of_IN developing_VBG corpus_NN uterine_NN cancer_NN if_IN she_PRP has_VBZ not_RB
          already_RB been_VBN diagnosed_VBN with_IN the_DT disease_NN or_CC has_VBZ had_VBN her_PRP$
          uterus_NN removed_VBN because_IN of_IN a_DT hysterectomy_NN ._. The_DT majority_NN of_IN
          women_NNS who_WP are_VBP diagnosed_VBN with_IN corpus_NN uterine_NN cancer_NN are_VBP
          treated_VBN with_IN a_DT hysterectomy_NN ._. The_DT percentage_NN of_IN corpus_NN
          uterine_NN cancer_NN cases_NNS that_WDT underwent_VBD a_DT hysterectomy_NN
          between_IN 1995_CD -_: 97_CD was_VBD 93_CD %_NN overall_JJ ,_, 85_CD %_NN for_IN ages_NNS 0_CD -_: 39_CD ,_, 98_CD %_NN
          for_IN ages_NNS 40_CD -_: 59_CD ,_, and_CC 91_CD %_NN for_IN ages_NNS 60_CD and_CC older_JJR [_NN 9_CD ]_NN ._.
          Thus_RB ,_, the_DT prevalence_NN (_( 
          P_NN 
          
            x_SYM 
           )_) derived_VBN using_VBG the_DT life-table_JJ method_NN involves_VBZ the_DT
          age-specific_JJ number_NN of_IN hysterectomies_NNS plus_CC women_NNS
          diagnosed_VBN with_IN corpus_NN uterine_NN cancer_NN who_WP did_VBD not_RB undergo_VB
          a_DT hysterectomy_NN (_( i_NNP ._. e_SYM ._. ,_, not_RB at_IN risk_NN )_) ._. In_IN the_DT survey_NN method_NN ,_,
          the_DT age-specific_JJ rate_NN of_IN women_NNS not_RB at_IN risk_NN of_IN corpus_NN
          uterine_NN cancer_NN divided_VBN by_IN the_DT age-specific_JJ rate_NN of_IN women_NNS
          having_VBG undergone_VBN a_DT hysterectomy_NN provided_VBD an_DT index_NN which_WDT
          was_VBD multiplied_VBN by_IN the_DT age-specific_JJ hysterectomy_NN
          prevalence_NN obtained_VBN from_IN the_DT BRFSS_NNP to_TO get_VB an_DT estimate_NN of_IN
          prevalent_JJ proportion_NN of_IN women_NNS not_RB at_IN risk_NN of_IN corpus_NN
          uterine_NN cancers_NNS ._.
        
        
          Corrected_NNP incidence_NN rates_NNS of_IN cancers_NNS of_IN the_DT corpus_NN
          uterine_NN
          Conventional_JJ cancer_NN incidence_NN rates_NNS are_VBP derived_VBN as_IN 
          R_NN 
          
            x_SYM 
           =_SYM 
          C_NNP 
          
            x_SYM 
           /_NN 
          L_NNP 
          
            x_SYM 
           ,_, where_WRB 
          C_NNP 
          
            x_SYM 
           is_VBZ the_DT age-specific_JJ number_NN of_IN cancer_NN cases_NNS and_CC 
          L_NNP 
          
            x_SYM 
           is_VBZ the_DT mid-year_JJ population_NN from_IN cross-sectional_JJ
          census_NN dat_NN ._. Corrected_NNP rates_NNS are_VBP derived_VBN as_IN :_:
          
          for_IN x_SYM =_SYM 0_CD -_: 4_CD ,_, 5_CD -_: 9_CD ,_, ._. ._. ._. ,_, 80_CD -_: 84_CD ,_, 85_CD +_NN ._.
        
        
          Lifetime_NNP and_CC age-conditional_JJ probability_NN
          estimates_NNS
          Lifetime_NNP and_CC age-conditional_JJ probability_NN (_( risk_NN )_)
          estimates_NNS of_IN being_VBG diagnosed_VBN with_IN cancer_NN are_VBP derived_VBN
          using_VBG life-table_JJ methods_NNS ._. Conventional_JJ lifetime_NN and_CC
          age-conditional_JJ probability_NN estimates_NNS of_IN being_VBG diagnosed_VBN
          with_IN cancer_NN are_VBP corrected_VBN for_IN the_DT prevalence_NN of_IN the_DT
          cancer_NN ._. This_DT involves_VBZ multiplying_VBG the_DT cancer_NN incidence_NN
          rate_NN used_VBN in_IN the_DT computation_NN of_IN the_DT probability_NN estimates_NNS
          by_IN 
          p_NN 1_CD 
          
            x_SYM 
           /_NN 
          p_NN 2_CD 
          
            x_SYM 
           =_SYM 1_CD /_NN (_( 1_CD -_: 
          P_NN 
          
            x_SYM 
           )_) ._. The_DT two_CD methods_NNS for_IN obtaining_VBG 
          P_NN 
          
            x_SYM 
           are_VBP described_VBN above_IN ._. A_DT complete_JJ description_NN of_IN the_DT
          method_NN for_IN deriving_VBG lifetime_NN and_CC age-conditional_JJ
          probability_NN estimates_NNS of_IN being_VBG diagnosed_VBN with_IN cancer_NN is_VBZ
          given_VBN elsewhere_RB [_NN 8_CD ]_NN ._. Probability_NNP estimates_NNS of_IN
          developing_VBG cancer_NN are_VBP reported_VBN across_IN the_DT age_NN span_NN and_CC
          interpreted_VBN as_IN the_DT probability_NN that_IN the_DT average_JJ child_NN
          born_VBN today_NN will_MD be_VB diagnosed_VBN with_IN the_DT disease_NN by_IN age_NN 
          x_SYM ._. This_DT statistic_NN assumes_VBZ that_IN the_DT
          current_JJ rates_NNS upon_IN which_WDT the_DT probability_NN estimates_NNS are_VBP
          based_VBN will_MD remain_VB constant_JJ over_IN the_DT child_NN 's_POS lifetime_NN ._.
          Given_VBN that_IN current_JJ rates_NNS are_VBP unlikely_JJ to_TO remain_VB constant_JJ
          over_IN an_DT extended_VBN period_NN of_IN time_NN ,_, and_CC that_IN persons_NNS are_VBP
          more_RBR likely_JJ interested_VBN in_IN their_PRP$ chance_NN of_IN developing_VBG the_DT
          cancer_NN from_IN their_PRP$ current_JJ ages_NNS onward_NN ,_, short-term_JJ ,_,
          age-conditional_JJ probability_NN estimates_NNS are_VBP perhaps_RB more_RBR
          relevant_JJ [_NN 10_CD ]_NN ._. Both_DT types_NNS of_IN probability_NN estimates_NNS are_VBP
          reported_VBN in_IN this_DT paper_NN ._.
        
        
          Diagnostic_NNP and_CC procedure_NN codes_NNS
          The_DT Utah_NNP Cancer_NNP Registry_NNP identifies_VBZ cancer_NN using_VBG the_DT
          International_NNP Classification_NNP of_IN Disease_NNP ,_, Second_NNP Edition_NNP
          (_( ICD-_NNP 02_CD )_) [_NN 11_CD ]_NN ._. Invasive_NNP cancers_NNS of_IN the_DT corpus_NN uteri_NN
          and_CC other_JJ uterus_NN not_RB otherwise_RB specified_VBN (_( hereafter_RB
          called_VBN corpus_NN uteri_NN )_) are_VBP identified_VBN as_IN C_NNP 540_CD -_: C_NNP 549_CD and_CC
          C_NNP 559_CD ._. Hysterectomy_NNP is_VBZ defined_VBN as_IN International_NNP
          Classification_NNP of_IN Disease_NNP ,_, Ninth_NNP Revision_NNP ,_, Clinical_NNP
          Modification_NNP (_( ICD-_NNP 9_CD -_: CM_NNP )_) procedure_NN codes_NNS 68_CD ._. 3_LS to_TO 68_CD ._. 8_CD ,_,
          where_WRB 68_CD ._. 3_LS to_TO 68_CD ._. 4_LS reflect_VB abdominal_NN hysterectomy_NN ,_, 68_CD ._. 5_LS
          reflects_VBZ vaginal_JJ hysterectomy_NN ,_, and_CC 68_CD ._. 6_CD to_TO 68_CD ._. 8_CD reflect_VB
          radical_JJ hysterectomy_NN [_NN 12_CD ]_NN ._.
        
        
          Data_NNP sources_NNS
          Data_NNS from_IN five_CD different_JJ sources_NNS were_VBD used_VBN in_IN the_DT
          analysis_NN :_: hysterectomy_NN cases_NNS obtained_VBN from_IN the_DT Hospital_NNP
          Discharge_NNP Data_NNP Base_NNP (_( HDDB_NNP )_) in_IN Utah_NNP ,_, hysterectomy_NN
          prevalence_NN obtained_VBN from_IN the_DT BRFSS_NNP ,_, invasive_JJ corpus_NN
          uterine_NN cancer_NN cases_NNS from_IN the_DT Utah_NNP Cancer_NNP Registry_NNP ,_,
          population_NN estimates_NNS from_IN the_DT United_NNP States_NNP Bureau_NNP of_IN the_DT
          Census_NNP ,_, and_CC mortality_NN data_NNS from_IN the_DT Utah_NNP State_NNP Health_NNP
          Department_NNP ._. Population_NN estimates_NNS of_IN the_DT female_JJ residents_NNS
          in_IN Utah_NNP were_VBD combined_VBN with_IN case_NN data_NNS to_TO compute_VB
          hysterectomy_NN incidence_NN rates_NNS ,_, prevalence_NN proportions_NNS ,_, and_CC
          invasive_JJ cancer_NN incidence_NN rates_NNS and_CC probabilities_NNS ._. Three_CD
          years_NNS of_IN data_NNS were_VBD considered_VBN in_IN order_NN to_TO provide_VB more_RBR
          stable_JJ estimates_NNS ._. The_DT influence_NN of_IN race_NN was_VBD not_RB
          considered_VBN because_IN of_IN the_DT high_JJ percentage_NN of_IN whites_NNS in_IN
          Utah_NNP (_( i_NNP ._. e_SYM ._. ,_, 95_CD %_NN White_NNP ,_, 2_CD %_NN Indian_JJ ,_, 2_CD %_NN Asian_JJ ,_, 1_CD %_NN Black_NNP )_) [_NN
          13_CD ]_NN ._.
          Fifty-five_NNP Utah_NNP hospitals_NNS submit_VBP data_NNS to_TO the_DT Utah_NNP
          Health_NNP Data_NNP Committee_NNP on_IN an_DT ongoing_JJ basis_NN ._. These_DT
          hospitals_NNS include_VBP nine_CD psychiatric_JJ facilities_NNS ,_, seven_CD
          specialty_NN hospitals_NNS ,_, and_CC the_DT Veterans_NNP Administration_NNP
          Medical_NNP Center_NNP ._. Shriners_NNP Hospital_NNP ,_, a_DT charity_NN hospital_NN ,_, is_VBZ
          exempt_JJ from_IN reporting_VBG requirements_NNS ._. These_DT hospitals_NNS
          report_VBP discharge_NN data_NNS (_( i_NNP ._. e_SYM ._. ,_, the_DT consolidation_NN of_IN
          complete_JJ billing_NN ,_, medical_JJ ,_, and_CC personal_JJ information_NN
          describing_VBG a_DT patient_NN ,_, the_DT services_NNS received_VBD ,_, and_CC the_DT
          charges_NNS billed_VBN )_) for_IN each_DT patient_NN served_VBD on_IN an_DT inpatient_NN
          basis_NN ._.
          Cancer_NN data_NNS were_VBD obtained_VBN from_IN the_DT Utah_NNP Cancer_NNP
          Registry_NNP ,_, which_WDT is_VBZ one_CD of_IN the_DT oldest_JJS in_IN the_DT country_NN ,_,
          originating_VBG in_IN 1966_CD ._. Since_IN 1973_CD ,_, the_DT Utah_NNP Cancer_NNP Registry_NNP
          has_VBZ participated_VBN in_IN the_DT Surveillance_NNP ,_, Epidemiology_NNP ,_, and_CC
          End_NN Results_NNS (_( SEER_NNP )_) Program_NN of_IN the_DT National_NNP Cancer_NNP
          Institute_NNP [_NN 1_CD ]_NN ._. The_DT registries_NNS in_IN the_DT SEER_NNP Program_NNP meet_VB
          high-quality_JJ standards_NNS and_CC are_VBP the_DT nation_NN 's_POS source_NN of_IN
          cancer_NN incidence_NN and_CC survival_NN data_NNS ._. Since_IN 1983_CD ,_, the_DT
          cancer_NN registries_NNS in_IN the_DT SEER_NNP Program_NNP have_VBP also_RB collected_VBN
          first_JJ course_NN of_IN cancer-directed_JJ therapy_NN ._. The_DT Utah_NNP Cancer_NNP
          Registry_NNP ensures_VBZ complete_JJ incidence_NN and_CC treatment_NN
          information_NN by_IN abstracting_VBG information_NN from_IN hospital_NN
          records_NNS ,_, clinical_JJ and_CC nursing_VBG home_NN records_NNS ,_, private_JJ
          pathology_NN laboratories_NNS and_CC radiotherapy_NN units_NNS ,_, and_CC death_NN
          certificates_NNS ._.
          The_DT BRFSS_NNP is_VBZ a_DT state-based_JJ surveillance_NN system_NN active_JJ
          in_IN all_DT 50_CD states_NNS ._. Since_IN the_DT early_JJ 1980_CD s_VBZ ,_, the_DT Center_NNP for_IN
          Disease_NNP Control_NNP and_CC Prevention_NNP has_VBZ collaborated_VBD with_IN
          states_NNS to_TO develop_VB questions_NNS that_WDT would_MD reveal_VB adults_NNS '_POS
          knowledge_NN ,_, attitudes_NNS ,_, and_CC practices_NNS related_VBN to_TO health_NN
          issues_NNS ._. Since_IN 1984_CD Utah_NNP has_VBZ been_VBN involved_VBN in_IN collecting_VBG
          data_NNS for_IN the_DT BRFSS_NNP ._.
          Age-specific_NNP corpus_NN uterine_NN rates_NNS are_VBP fit_VBN using_VBG
          second-_NN or_CC third-order_JJ polynomial_NN models_NNS ._.
        
      
      
        Results_NNS
        Numbers_NNPS and_CC crude_NN rates_NNS of_IN hysterectomy_NN per_IN 10_CD ,_, 000_CD in_IN
        Utah_NNP are_VBP shown_VBN for_IN 1992_CD -_: 94_CD and_CC 1995_CD -_: 97_CD (_( Table_NNP 1_LS )_) ._. The_DT rates_NNS
        increase_VBP early_RB in_IN life_NN ,_, peak_NN ,_, and_CC then_RB decrease_VB over_IN the_DT
        older_JJR ages_NNS ._. The_DT rates_NNS were_VBD significantly_RB higher_JJR in_IN 1992_CD -_: 94_CD ,_,
        compared_VBN to_TO 1995_CD -_: 97_CD ,_, in_IN the_DT age_NN groups_NNS 25_CD -_: 34_CD and_CC 35_CD -_: 44_CD ._.
        Estimates_NNS of_IN hysterectomy_NN prevalence_NN based_VBN on_IN the_DT
        life-table_JJ method_NN and_CC the_DT survey_NN method_NN are_VBP presented_VBN in_IN
        Figure_NN 1_CD ._. Higher_JJR prevalence_NN estimates_NNS based_VBN on_IN the_DT
        life-table_JJ method_NN with_IN 1992_CD -_: 94_CD data_NNS versus_CC 1995_CD -_: 97_CD data_NNS
        reflect_VBP lower_JJR hysterectomy_NN rates_NNS in_IN the_DT later_JJ time_NN period_NN
        for_IN most_JJS ages_NNS ._. Prevalence_NNP estimates_NNS based_VBN on_IN the_DT BRFSS_NNP
        1995_CD -_: 97_CD are_VBP highest_JJS ,_, particularly_RB for_IN women_NNS aged_VBN 45_CD through_IN
        69_CD ._.
        During_IN 1995_CD -_: 97_CD ,_, there_EX were_VBD 549_CD cases_NNS of_IN invasive_JJ cancer_NN
        of_IN the_DT corpus_NN uteri_NN in_IN Utah_NNP ._. The_DT age-adjusted_JJ rate_NN was_VBD 20_CD
        per_IN 100_CD ,_, 000_CD ._. This_DT conventionally_RB derived_VBN rate_NN is_VBZ based_VBN on_IN
        the_DT denominator_NN of_IN the_DT rate_NN calculation_NN including_VBG women_NNS who_WP
        are_VBP not_RB at_IN risk_NN of_IN being_VBG diagnosed_VBN with_IN invasive_JJ cancer_NN of_IN
        the_DT corpus_NN uterine_NN ._. Figure_NN 2_CD presents_VBZ corrected_VBN and_CC
        uncorrected_JJ population_NN denominators_NNS with_IN the_DT corrections_NNS
        based_VBN on_IN the_DT two_CD methods_NNS ._. Applying_VBG the_DT corrected_VBN
        populations_NNS ,_, the_DT age-adjusted_JJ rates_NNS using_VBG the_DT life_NN -_: table_NN
        method_NN became_VBD 32_CD with_IN 1995_CD -_: 97_CD data_NNS ,_, 34_CD with_IN 1992_CD -_: 94_CD data_NNS ,_,
        and_CC using_VBG the_DT survey_NN method_NN was_VBD 37_CD ._.
        Figure_NN 3_CD presents_VBZ corrected_VBN and_CC uncorrected_JJ invasive_JJ
        cancer_NN incidence_NN rates_NNS of_IN the_DT corpus_NN uteri_NN in_IN Utah_NNP ._. The_DT
        correction_NN for_IN hysterectomy_NN prevalence_NN was_VBD greatest_JJS among_IN
        women_NNS ages_NNS 75_CD -_: 79_CD ._. In_IN this_DT age_NN group_NN ,_, the_DT uncorrected_JJ rate_NN
        was_VBD 125_CD per_IN 100_CD ,_, 000_CD and_CC the_DT corrected_VBN rate_NN using_VBG the_DT
        life-table_JJ method_NN was_VBD 223_CD based_VBN on_IN 1995_CD -_: 97_CD data_NNS ,_, 243_CD based_VBN
        on_IN 1992_CD -_: 94_CD data_NNS ,_, and_CC the_DT corrected_VBN rate_NN using_VBG the_DT survey_NN
        method_NN was_VBD 228_CD ._.
        The_DT lifetime_NN probability_NN of_IN developing_VBG corpus_NN uterine_NN
        cancer_NN was_VBD 2_CD ._. 6_CD %_NN (_( uncorrected_JJ )_) ;_: and_CC corrected_VBN ,_, based_VBN on_IN the_DT
        life-table_JJ method_NN ,_, was_VBD 4_CD ._. 2_CD %_NN using_VBG 1995_CD -_: 97_CD data_NNS ,_, 4_CD ._. 5_CD %_NN using_VBG
        1992_CD -_: 94_CD data_NNS ;_: and_CC according_VBG to_TO the_DT survey_NN method_NN was_VBD 4_CD ._. 6_CD %_NN ._.
        Corresponding_VBG percentages_NNS women_NNS free_JJ of_IN the_DT disease_NN at_IN age_NN
        50_CD are_VBP slightly_RB lower_RBR ,_, 2_CD ._. 5_CD %_NN ,_, 4_CD ._. 1_CD %_NN ,_, 4_CD ._. 4_CD %_NN ,_, and_CC for_IN 4_CD ._. 5_CD %_NN ._.
        Table_NNP 2_CD shows_VBZ the_DT corrected_VBN and_CC uncorrected_JJ number_NN per_IN
        100_CD ,_, 000_CD invasive_JJ cancers_NNS of_IN the_DT corpus_NN uteri_NN expected_VBN in_IN
        Utah_NNP over_IN the_DT next_JJ 10_CD years_NNS among_IN women_NNS aged_VBN 
        x_SYM ._. Ten-year_NNP probability_NN estimates_NNS
        are_VBP largely_RB influenced_VBN by_IN the_DT age_NN in_IN which_WDT they_PRP are_VBP
        conditioned_VBN ._. The_DT 10_CD -_: year_NN probability_NN of_IN being_VBG diagnosed_VBN
        with_IN cancer_NN of_IN the_DT corpus_NN uterine_NN is_VBZ greatest_JJS for_IN women_NNS
        aged_VBN 65_CD ._. The_DT corrections_NNS increase_VBP these_DT probabilities_NNS
        considerably_RB ,_, most_RBS noticeably_RB for_IN those_DT corrected_VBN using_VBG the_DT
        survey_NN method_NN ._.
      
      
        Discussion_NNP
        This_DT paper_NN presents_VBZ two_CD methods_NNS for_IN obtaining_VBG corrected_VBN
        corpus_NN uterine_NN cancer_NN incidence_NN rates_NNS and_CC probabilities_NNS ._. In_IN
        the_DT life-table_JJ method_NN ,_, hysterectomy_NN or_CC corpus_NN uterine_NN
        cancer_NN prevalence_NN estimates_NNS were_VBD derived_VBN from_IN
        cross-sectional_JJ hysterectomy_NN ,_, corpus_NN uterine_NN ,_, and_CC all-cause_JJ
        mortality_NN data_NNS applied_VBN to_TO life_NN tables_NNS ._. In_IN the_DT survey_NN
        method_NN ,_, hysterectomy_NN prevalence_NN estimates_NNS were_VBD obtained_VBN
        directly_RB from_IN BRFSS_NNP data_NNS ._. The_DT purpose_NN of_IN the_DT correction_NN was_VBD
        to_TO adjust_VB the_DT population_NN values_NNS used_VBN in_IN the_DT calculations_NNS in_IN
        order_NN to_TO reflect_VB the_DT at-risk_JJ population_NN for_IN developing_VBG
        corpus_NN uterine_NN cancer_NN ._.
        Both_DT methods_NNS have_VBP the_DT advantage_NN that_IN several_JJ years_NNS of_IN
        follow-up_JJ data_NNS are_VBP not_RB required_VBN to_TO determine_VB the_DT at-risk_JJ
        population_NN ._. Hence_RB ,_, for_IN areas_NNS of_IN the_DT world_NN that_WDT do_VBP not_RB have_VB
        sufficient_JJ years_NNS of_IN hysterectomy_NN or_CC cancer_NN data_NNS to_TO directly_RB
        compute_VB prevalence_NN ,_, corrected_VBN rates_NNS and_CC probabilities_NNS can_MD
        still_RB be_VB obtained_VBN ._. However_RB ,_, the_DT life-table_JJ method_NN is_VBZ
        limited_VBN by_IN trends_NNS in_IN the_DT data_NNS ._. Because_IN the_DT hysterectomy_NN
        rates_NNS were_VBD lower_JJR in_IN 1995_CD -_: 97_CD than_IN in_IN previous_JJ years_NNS ,_, the_DT
        prevalence_NN estimates_NNS based_VBN on_IN these_DT years_NNS underestimated_VBD
        the_DT prevalence_NN of_IN this_DT procedure_NN ._. Use_NN of_IN the_DT higher_JJR
        incidence_NN rates_NNS in_IN 1992_CD -_: 94_CD produced_VBN higher_JJR hysterectomy_NN
        prevalence_NN estimates_NNS across_IN the_DT age_NN span_NN ._. However_RB ,_,
        prevalence_NN based_VBN on_IN these_DT rates_NNS may_MD also_RB have_VB been_VBN
        underestimated_VBN ,_, at_IN least_JJS through_IN ages_NNS 69_CD ,_, as_IN suggested_VBN by_IN
        the_DT hysterectomy_NN prevalence_NN estimates_NNS from_IN the_DT survey_NN
        method_NN ._.
        According_VBG to_TO a_DT self-reported_JJ national_JJ survey_NN ,_,
        hysterectomies_NNS have_VBP remained_VBN stable_JJ between_IN 1965_CD -_: 95_CD [_NN 14_CD ]_NN
        ._. However_RB ,_, based_VBN on_IN the_DT National_NNP Hospital_NNP Discharge_NNP Survey_NNP ,_,
        there_EX is_VBZ evidence_NN that_IN hysterectomy_NN rates_NNS decreased_VBD
        slightly_RB from_IN the_DT mid_JJ 1970_CD s_VBZ through_IN the_DT 1980_CD s_VBZ and_CC then_RB may_MD
        have_VB leveled_VBN off_RP through_IN 1993_CD [_NN 4_CD 15_CD 16_CD ]_NN ._. Our_PRP$ results_NNS
        show_VBP that_DT hysterectomy_NN in_IN Utah_NNP significantly_RB decreased_VBD
        between_IN 1992_CD -_: 94_CD and_CC 1995_CD -_: 97_CD in_IN the_DT age_NN groups_NNS 25_CD -_: 34_CD and_CC
        35_CD -_: 44_CD ,_, where_WRB hysterectomy_NN is_VBZ most_RBS common_JJ ._. This_DT suggests_VBZ
        that_DT hysterectomy_NN prevalence_NN based_VBN on_IN the_DT cross-sectional_JJ
        method_NN ,_, at_IN least_JJS for_IN ages_NNS less_JJR than_IN 55_CD based_VBN on_IN 1995_CD -_: 97_CD
        data_NNS ,_, underestimates_NNS hysterectomy_NN prevalence_NN ._. Use_NN of_IN the_DT
        survey_NN method_NN to_TO obtain_VB prevalence_NN has_VBZ the_DT advantage_NN that_IN
        it_PRP does_VBZ not_RB require_VB complicated_VBN modeling_NN and_CC is_VBZ not_RB
        influenced_VBN by_IN trends_NNS ,_, but_CC it_PRP may_MD or_CC may_MD not_RB represent_VB the_DT
        Utah_NNP population_NN ,_, given_VBN potential_JJ biases_NNS that_WDT may_MD influence_VB
        self-reported_JJ responses_NNS ._. Yet_RB a_DT high_JJ level_NN of_IN correspondence_NN
        has_VBZ been_VBN previously_RB shown_VBN to_TO exist_VB between_IN self-reports_JJ and_CC
        hospital_NN records_NNS of_IN hysterectomy_NN [_NN 17_CD ]_NN ._.
        In_IN an_DT earlier_JJR report_NN by_IN Merrill_NNP and_CC Feuer_NNP [_NN 2_CD ]_NN ,_, based_VBN
        on_IN 1990_CD -_: 92_CD national_JJ data_NNS ,_, the_DT hysterectomy_NN prevalence_NN
        correction_NN based_VBN on_IN an_DT historical_JJ ,_, rather_RB than_IN a_DT
        cross-sectional_JJ ,_, approach_NN increased_VBD the_DT age-adjusted_JJ rates_NNS
        of_IN corpus_NN uterine_NN rates_NNS from_IN 22_CD ._. 2_LS to_TO 33_CD ._. 0_CD ._. Although_IN we_PRP
        cannot_NN compare_VB our_PRP$ results_NNS directly_RB because_IN of_IN difference_NN
        in_IN time_NN periods_NNS studied_VBN ,_, the_DT unique_JJ racial_JJ makeup_NN in_IN Utah_NNP ,_,
        and_CC because_IN we_PRP also_RB incorporated_VBD the_DT prevalence_NN of_IN corpus_NN
        uterine_NN cancer_NN cases_NNS not_RB treated_VBN with_IN a_DT hysterectomy_NN ,_, the_DT
        magnitude_NN of_IN the_DT correction_NN is_VBZ similar_JJ to_TO those_DT reported_VBD in_IN
        this_DT prior_JJ study_NN ._.
        As_IN anticipated_VBN ,_, the_DT hysterectomy_NN prevalence_NN corrections_NNS
        had_VBD large_JJ influences_NNS on_IN the_DT rates_NNS and_CC probabilities_NNS ._. The_DT
        percentage_NN increase_NN was_VBD smallest_JJS earlier_RBR in_IN life_NN and_CC
        increased_VBN consistently_RB with_IN age_NN ._. This_DT is_VBZ because_IN the_DT number_NN
        of_IN women_NNS alive_JJ that_WDT have_VBP undergone_VBN a_DT hysterectomy_NN increases_NNS
        over_IN the_DT age_NN span_NN ,_, as_IN evident_JJ in_IN the_DT corrected_VBN versus_CC the_DT
        uncorrected_JJ rates_NNS and_CC probabilities_NNS ._. Yet_RB ,_, although_IN the_DT
        percentage_NN change_NN increases_NNS with_IN age_NN ,_, the_DT greatest_JJS absolute_JJ
        change_NN tends_VBZ to_TO be_VB where_WRB the_DT cancer_NN rates_NNS are_VBP largest_JJS ._.
        It_PRP should_MD be_VB emphasized_VBN that_IN correcting_VBG the_DT rates_NNS and_CC
        probabilities_NNS had_VBD a_DT large_JJ impact_NN because_IN of_IN the_DT high_JJ
        prevalence_NN of_IN hysterectomy_NN ._. The_DT additional_JJ influence_NN of_IN
        prevalent_JJ cases_NNS of_IN corpus_NN uterine_NN cancer_NN cases_NNS who_WP had_VBD not_RB
        undergone_VBN a_DT hysterectomy_NN was_VBD relatively_RB very_RB small_JJ ._. Several_JJ
        studies_NNS have_VBP explored_JJ the_DT benefits_NNS ,_, risks_NNS ,_, and_CC costs_NNS of_IN
        hysterectomy_NN [_NN 18_CD 19_CD 20_CD 21_CD 22_CD 23_CD 24_CD 25_CD 26_CD 27_CD 28_CD ]_NN ._. Despite_IN
        the_DT potential_JJ risks_NNS and_CC costs_NNS associated_VBN with_IN this_DT medical_JJ
        procedure_NN ,_, over_IN 35_CD %_NN of_IN women_NNS in_IN the_DT United_NNP States_NNPS received_VBD
        a_DT hysterectomy_NN by_IN age_NN 50_CD [_NN 2_CD ]_NN ._. Hysterectomies_NNP are_VBP
        primarily_RB performed_VBN for_IN nonmalignant_NN conditions_NNS [_NN 3_CD 4_CD ]_NN ,_,
        with_IN the_DT expectation_NN that_IN the_DT benefits_NNS of_IN the_DT surgery_NN
        outweigh_VBP the_DT risks_NNS ._.
        Given_VBN the_DT high_JJ percentage_NN of_IN whites_NNS in_IN Utah_NNP ,_, the_DT study_NN
        results_NNS primarily_RB reflect_VBP this_DT race_NN ._. Hence_RB ,_, comparison_NN of_IN
        the_DT results_NNS to_TO other_JJ geographic_JJ locations_NNS should_MD be_VB
        restricted_VBN to_TO primarily_RB white_JJ populations_NNS ._. Yet_RB the_DT results_NNS
        provide_VBP an_DT important_JJ baseline_NN for_IN future_JJ comparisons_NNS ._.
        In_IN addition_NN to_TO the_DT limitations_NNS stated_VBN above_IN ,_, because_IN it_PRP
        is_VBZ impractical_JJ to_TO expect_VB cross-sectional_JJ rates_NNS upon_IN which_WDT
        lifetime_NN and_CC age-conditional_JJ cancer_NN probabilities_NNS are_VBP based_VBN
        to_TO remain_VB constant_JJ in_IN the_DT long_JJ run_NN ,_, lifetime_NN probabilities_NNS
        of_IN cancer_NN are_VBP less_RBR reliable_JJ than_IN shorter_JJR term_NN ,_,
        age-conditional_JJ probability_NN estimates_NNS ._. They_PRP are_VBP also_RB less_RBR
        relevant_JJ to_TO a_DT woman_NN already_RB aged_VBN to_TO mid-life_JJ ._. However_RB ,_,
        lifetime_NN probability_NN estimates_NNS of_IN cancer_NN may_MD provide_VB a_DT
        guide_NN to_TO individuals_NNS and_CC health_NN policy_NN officials_NNS as_IN to_TO the_DT
        burden_NN of_IN these_DT select_VB cancers_NNS ._.
        As_IN already_RB well_RB established_VBN ,_, an_DT accurate_JJ representation_NN
        of_IN the_DT expected_VBN risk_NN of_IN corpus_NN uterine_NN cancer_NN requires_VBZ that_IN
        the_DT population_NN in_IN the_DT incidence-rate_JJ calculation_NN be_VB
        corrected_VBN to_TO reflect_VB the_DT at-risk_JJ population_NN ._. Similarly_RB ,_, an_DT
        accurate_JJ measure_NN of_IN the_DT burden_NN of_IN this_DT cancer_NN ,_, in_IN terms_NNS of_IN
        lifetime_NN and_CC age-conditional_JJ probabilities_NNS of_IN developing_VBG
        the_DT disease_NN ,_, also_RB requires_VBZ a_DT population_NN correction_NN to_TO
        reflect_VB those_DT women_NNS at_IN risk_NN ._. The_DT two_CD methods_NNS developed_VBN in_IN
        this_DT study_NN reflect_VB unique_JJ strengths_NNS and_CC weaknesses_NNS ._. Yet_RB
        despite_IN their_PRP$ potential_JJ weaknesses_NNS and_CC in_IN the_DT absence_NN of_IN
        long-term_JJ hysterectomy_NN and_CC cancer_NN data_NNS ,_, they_PRP will_MD provide_VB
        more_RBR reasonable_JJ estimates_NNS of_IN the_DT rates_NNS and_CC probabilities_NNS of_IN
        corpus_NN uterine_NN cancer_NN ._.
      
      
        Competing_VBG Interests_NNP
        None_NN declared_VBD
      
    
  
